- Home
- BLKB vs ICUI Comparison
BLKB vs ICUI Comparison
Compare BLKB & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLKB
- ICUI
- Stock Information
- Founded
- BLKB 1981
- ICUI 1984
- Country
- BLKB United States
- ICUI United States
- Employees
- BLKB N/A
- ICUI N/A
- Industry
- BLKB Computer Software: Prepackaged Software
- ICUI Medical/Dental Instruments
- Sector
- BLKB Technology
- ICUI Health Care
- Exchange
- BLKB Nasdaq
- ICUI Nasdaq
- Market Cap
- BLKB 3.8B
- ICUI 3.8B
- IPO Year
- BLKB 2004
- ICUI 1992
- Fundamental
- Price
- BLKB $75.10
- ICUI $161.08
- Analyst Decision
- BLKB Hold
- ICUI Buy
- Analyst Count
- BLKB 3
- ICUI 4
- Target Price
- BLKB $86.67
- ICUI $199.67
- AVG Volume (30 Days)
- BLKB 185.2K
- ICUI 200.3K
- Earning Date
- BLKB 02-10-2025
- ICUI 02-25-2025
- Dividend Yield
- BLKB N/A
- ICUI N/A
- EPS Growth
- BLKB N/A
- ICUI N/A
- EPS
- BLKB 0.99
- ICUI N/A
- Revenue
- BLKB $1,148,274,000.00
- ICUI $2,340,097,000.00
- Revenue This Year
- BLKB $6.75
- ICUI $4.38
- Revenue Next Year
- BLKB $5.76
- ICUI $0.34
- P/E Ratio
- BLKB $76.64
- ICUI N/A
- Revenue Growth
- BLKB 5.81
- ICUI 4.04
- 52 Week Low
- BLKB $66.47
- ICUI $86.80
- 52 Week High
- BLKB $88.95
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- BLKB 40.39
- ICUI 51.79
- Support Level
- BLKB $73.74
- ICUI $151.92
- Resistance Level
- BLKB $75.47
- ICUI $167.49
- Average True Range (ATR)
- BLKB 1.23
- ICUI 4.52
- MACD
- BLKB 0.25
- ICUI 0.73
- Stochastic Oscillator
- BLKB 58.43
- ICUI 61.01
About BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.